Phospho-Myosin Light Chain 2 (Thr18/Ser19) Antibody

About the Target

MYL9 is a target of interest in many antibody-based workflows. Phospho-Myosin Light Chain 2 (Thr18/Ser19) (MLC2) refers to the regulatory light chain of myosin II, which is phosphorylated at threonine 18 (Thr18) and serine 19 (Ser19) residues by myosin light chain kinase (MLCK) and other kinases. Structurally, MLC2 is composed of a single polypeptide associated with the myosin heavy chain, and its N-terminal region contains the key phosphorylation sites that regulate myosin motor activity. Depending on the literature source, MYL9 may also be discussed as Phospho-Myosin Light Chain 2 (Thr18/Ser19) and Myosin regulatory light polypeptide 9.

Reported cellular context includes cytoplasm and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following MYL9 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MYL9 is commonly interpreted in the context of cardiovascular and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and cytoskeleton across matched conditions
• changes linked to vascular, contractile, or hemodynamic cell-state cues
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MYL9. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MYL9 reflect biology rather than handling. When interpreting MYL9, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MYL9 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.